Location: Home
  • search
  • go
  • Relate News
  • 9/14/2023China to Manage Monkeypox as Category B Infectious Disease as Covid-19
  • 9/14/2023U.S.-China Track II Dialogue on Healthcare - July 2023 Consensus
  • 9/13/2023Are China's Healthcare and Biopharma Sectors Really Open for Investmen...
  • 9/13/2023AriBio, Shanghai Pharma to Commercialize Oral Alzheimer's Drug AR1001
  • 9/13/2023Clover Biopharma Launches Quadrivalent Influenza Vaccine in Mainland C...
  • 9/13/2023NHSA Issues the Notice on Further Advancing the Intelligent Review and...
  • 9/8/2023Recent Official and Executive Moves
  • 9/7/2023MSD Plans to Boost New Product Launch and Pharma R&D in China
  • 9/6/2023NMPA Solicits Comments on the Guidelines for the Inspection of Third-P...
  • 9/1/2023NHSA Issues the List of Drugs Passing Preliminary Form Evaluation for ...
  • 9/1/2023Recent Executive Moves
  • 8/31/2023IQVIA: Chinese Retail Pharmacy Sales up 8.9% in MAT Q2/2023
  • 8/31/2023NMPA and Chinese Customs Announce Addition of Taizhou as a Drug Import...
  • 8/31/2023NHSA to Cancel Hospital Payment Rights for Drug and Consumable Procure...
  • 8/31/2023MC2 Thera and Huadong Pharma Enter LIcense Deal for Plague Psoriasis D...
  • 8/31/2023Recent Official and Executive Moves
  • 8/30/2023Review of Rising Sales Expenditures Trend of A and H Share-Listed Chin...
  • 8/29/2023NMPA Announces OTC Switch of Paracetamol Orally Dispersion Tablet
  • 8/29/2023Former Star Official of China's Healthcare Reform and VBP Architect ...
  • 8/29/2023Mounjaro's China Approval Imminent as Domestic Competitors Enter Clini...
  • 8/28/2023Regulation of Drug and Medical Device Advertising in China: An Industr...
  • 8/28/2023Verastem Oncology Enters Partnerships with GenFleet Therapeutics to Ad...
  • 8/25/2023Domestic Pharma Sealed Ten Outlicensing Deals in H1/2023 (Updated)
  • 8/25/2023IQVIA: Overall Chinese Pharma Market Growth Up 0.3% in 2022
  • 8/25/2023State Council Adopts New Action Plan for High-quality Development of P...
  • 8/25/2023China: The Latest Medtech Access Policies and Implications
  • 8/24/2023Review of China Performance of Leading MNCs in China H1/2023 (Updated)
  • 8/24/2023CMS Licenses China Rights of Class 1 Anti-Ischemic Stroke New Drug fro...
  • 8/23/2023What China's New Patent Linkage and Patent Term Extension Systems Mean...
  • 8/23/2023Increasingly, State Investment and Middle Eastern Sovereign Wealth Are...
  • Page:46/360 Total number of articles:10791: [First][<<] [44] [45] [46] [47] [48] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group